Venom immunotherapy in children and adolescents: Efficacy and safety in an Italian tertiary allergy center
Pediatric Allergy and Immunology · 2026-08 · 37 (8)
DOI: 10.1111/pai.70466 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 17.08.2026. Verfasst von Valentina Gueli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Specialization in Allergy and Clinical Immunology, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Venom Hypersensitivity, Desensitization, Immunologic, Insect Bites and Stings, Arthropod Venoms. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Hymenoptera venom allergy (HVA) is a potentially life‐threatening condition and the second most common cause of severe allergic reactions in children after food allergy. The risk of recurrence of systemic reaction is approximately 32% in untreated children; therefore, these patients need to undergo diagnostic tests and, if indicated, venom immunotherapy (VIT). However real‐life data on VIT in children remain limited.
Methods
We conducted an observational study in a cohort of children and adolescents ( n = 40) with HVA and treated with VIT in an Italian tertiary allergy center between 1999 and 2023. Data included demographic features, index reaction, pre‐existing risk factors, timeline of VIT, adverse reactions to VIT, re‐sting outcomes and serological exams were analyzed.
Results
The cohort was predominantly male (87.5%). Adverse reactions to VIT were infrequent, occurred mainly as local reactions, and showed low rates per injection. Among patients who completed ≥3 or ≥5 years of VIT, no severe systemic reactions were observed during treatment and epinephrine was never required. Re‐stings during VIT were common, occurring up to 75.0%, mainly during the maintenance phase. Reactions were mild and limited to cutaneous symptoms. Among patients re‐stung after completion of VIT (9/27 patients, 33%), no systemic reactions were observed and no epinephrine was required. Venom‐specific IgE levels significantly decreased after completion of VIT ( p = .004).
Conclusions
The EAACI guidelines provide general recommendations for children, but many are based on limited pediatric evidence. This study provides additional data about the favorable safety profile and efficacy of VIT in children and adolescents with HVA. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, School of Specialization in Allergy and Clinical Immunology, University of Verona, Verona, Italy.
- Azienda ULSS8 Berica, Allergy Unit, Vicenza, Italy.
- Department of Diagnostics and Public Health, Section of Medical Statistics, University of Verona, Verona, Italy.
- Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy.
- Allergy Unit, San Bortolo Hospital, Vicenza, Italy.
ORCID-Profile: Valentina Gueli, Francesca Norelli, Giovanna Sfriso, Bianca Olivieri, Francesca Nalin, Giorgia Marta, Patrizia Bonadonna
Zitieren
APA
Gueli, V., Norelli, F., Taus, F., Sfriso, G., Olivieri, B., Nalin, F., Marta, G., Olivieri, E., & Bonadonna, P. (2026). Venom immunotherapy in children and adolescents: Efficacy and safety in an Italian tertiary allergy center. Pediatric Allergy and Immunology, 37(8). https://doi.org/10.1111/pai.70466
Vancouver
Gueli V, Norelli F, Taus F, Sfriso G, Olivieri B, Nalin F, et al. Venom immunotherapy in children and adolescents: Efficacy and safety in an Italian tertiary allergy center. Pediatric Allergy and Immunology. 2026;37(8). doi:10.1111/pai.70466
BibTeX
@article{Gueli2026,
author = {Gueli, Valentina and Norelli, Francesca and Taus, Francesco and Sfriso, Giovanna and Olivieri, Bianca and Nalin, Francesca and Marta, Giorgia and Olivieri, Elisa and Bonadonna, Patrizia},
title = {Venom immunotherapy in children and adolescents: Efficacy and safety in an Italian tertiary allergy center},
journal = {Pediatric Allergy and Immunology},
year = {2026},
volume = {37},
number = {8},
doi = {10.1111/pai.70466}
}
EUVIMED